Cyclophosphamide, bortezomib, and dexamethasone therapy in AL amyloidosis is associated with high clonal response rates and prolonged progression-free survival.
暂无分享,去创建一个
P. Hawkins | J. Pinney | C. Whelan | A. Wechalekar | T. Lane | H. Lachmann | J. Gillmore | S. Gibbs | C. Venner | L. Rannigan | D. Foard | Darren Foard